Endpoints Media Bias

Uncover sensationalism, opinion, and topical biases from Endpoints. Updated weekly.

         



Customize Your AI News Feed. No Censorship. No Ads.






Endpoints News Cycle (?):






Endpoints News Bias (?):

📉 Bearish <-> Bullish 📈:

📝 Prescriptive:

💭 Opinion:

ðŸ—ģ Political:

🏛ïļ Appeal to Authority:

👀 Covering Responses:

🗑ïļ Spam:

❌ Uncredible <-> Credible ✅:

ðŸĪ‘ Advertising:



Endpoints Social Media Impact (?): 5




Discussion:





Endpoints Most Begging The Question Articles


🔄 MarketingRx roundup: Study finds generic drugs gain ground, but docs still prefer brands; Pfizer lauded at AACR

Senator turns up heat on inhaler manufacturers to remove improperly listed Orange Book patents

✅ Only a small fraction of rare pediatric designations have led to vouchers, new FDA analysis shows




Endpoints Most Ideological Articles


ðŸšĻ Bristol Myers debuts first TV ad for heart condition drug Camzyos

The Bell Labs of biotech: Stuart Schreiber has billionaire support for new biomedical institute

💭 Humira biosimilar market remains stagnant, with AbbVie losing only 2% of market share, Samsung report shows




Endpoints Most Opinionated Articles


ðŸšĻ Argenx rolls out new campaign for rare autoimmune condition as it awaits FDA ruling

🏛ïļ Califf and Marks call for clinicians to help address 'large volume' of vaccine misinformation

💭 Pfizer and BioNTech urge US patent review board to take on Moderna's Covid patents




Endpoints Most Oversimplified Articles


Forta raises $55M to train families to be caregivers of patients with chronic illnesses

📈 Verona secures $400M financing arrangement with Oxford, Hercules as ensifentrine PDUFA date inches closer

🏛ïļ Bluebird snags more outcomes-based coverage for its $3M+ sickle cell gene therapy




Endpoints Most Advertorial Articles


📈 Inside Nvidia's plan to dominate biotech's AI revolution

🏛ïļ MarketingRx roundup: Cannes ad festival speakers to include Pfizer, Novo Nordisk; AZ adds TV commercial to NHL collab

📈 MarketingRx roundup: Viatris taps former Moderna exec for commercial chief; Merck debuts PAH effort




Endpoints Most Appeal to Authority Articles


ðŸšĻ Biotech job market bottoms out, hinting at potential comeback, according to Jefferies

🏛ïļ Califf and Marks call for clinicians to help address 'large volume' of vaccine misinformation

📈 Another pharma adds direct telehealth with Phathom's first campaign for acid blocker Voquezna




Endpoints Most Covering Responses


📈 Another pharma adds direct telehealth with Phathom's first campaign for acid blocker Voquezna

As PBMs face threats in Washington, industry trade group poured millions more into lobbying

🏛ïļ Califf and Marks call for clinicians to help address 'large volume' of vaccine misinformation




Endpoints Most Subjective Articles


💭 Allogene Therapeutics to restructure, deprioritize PhII CAR-T trials in clinical pivot

💭 #JPM24: Sanofi says it may look at next generation of weight loss drugs

📉 Bristol Myers' Abecma continues to face pressure ahead of FDA adcomm




Endpoints Most Pro-establishment Articles


📈 Thermo Fisher expects lasting benefits to bill targeting Chinese service providers

ðŸšĻ Biotech job market bottoms out, hinting at potential comeback, according to Jefferies

🏛ïļ Kristen Hege reaches the end of one trail, and the beginning of the next




Endpoints Most Fearful Articles


ðŸ˜Ļ The Change Healthcare hack could be a catalyst for real healthcare cybersecurity improvement

ðŸ˜Ļ Abeona handed a CRL for epidermolysis bullosa cell therapy

ðŸ˜Ļ Zealand drug hit with CRL for ultra-rare disease amid manufacturing concerns, plans to resubmit in 2024




Endpoints Most Gossipy Articles


ðŸ—Ģïļ FDA seizes thousands of counterfeit Ozempic units, warns consumers not to use

ðŸšĻ Shunned by insurers, digital therapeutics startups look for other ways to get paid

ðŸ—Ģïļ MarketingRx roundup: Pfizer jumps on latest TikTok trend; Novo recruits for CagriSema trial across languages




Endpoints Most Victimization Articles


ðŸ˜Ē Pharma companies to remain mum on CMS' initial offers next week for the first year of IRA negotiations

ðŸ˜Ē Updated: Lawsuit accuses UPenn and Jim Wilson of secretly profiting from former postdoc's work

ðŸ˜Ē Generic industry group sues Illinois over drug price law


Endpoints Most Overconfident Articles


Endpoints News wins a SABEW award for general excellence

Lutetium, actinium or lead: Can isotope type offer an edge in radiotherapy?

Longboard stock soars on heels of positive topline data for seizure medication




Endpoints Most Politically Conservative Articles


House Republicans call on FDA to hand over info on internal scientific disagreements

DeSantis, Johnson raise flags around Covid boosters as FDA maintains that they're safe and effective




Endpoints Most Prescriptive Articles    

✅ Esteve to acquire Perrigo's rare disease pharma business for up to $295M

✅ Walgreens will build out specialty pharmacy business, leaning into drug and therapy services

Optum is shutting down its virtual care business

✅ Shimadzu Corporation establishes three R&D centers in the US in anticipation of business expansion for pharmaceutical companies

J&J's multiple myeloma therapies drive oncology business despite slow Carvykti sales

✅ Catalent had several suitors, including another of its business partners, before Novo won out





Endpoints Recent Articles



Sort By:                     









Increase your understanding with more perspectives. No ads. No censorship.






×

Chat with Helium


 Ask any question about Endpoints bias!